Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
University of Calgary
$120,000.00
Blood Transfusion and Risk of CAA-Related Intracerebral Hemorrhage: A Nested Case-Control Study
EF 2025-26
Résumé
Cerebral amyloid angiopathy (CAA) is a condition in which beta amyloid accumulates in the brain's small blood vessels, making them fragile, contributing to roughly 20 to 50 percent of spontaneous intracerebral hemorrhages (ICH). Evidence suggests these beta amyloid fibrils may be transmissible via infected tissues, resembling prion diseases. Exploratory work found patients receiving blood from donors who later had multiple ICH events faced higher ICH risk, although the link to CAA was not explored. This study investigates whether receiving a blood transfusion is associated with increased odds of CAA related ICH, supporting possible prion like transmissibility of CAA through blood.
In this retrospective, nested case control study, we will use administrative data from 2001 to 2025 to identify patients with ICH. Brain scans will be reviewed to confirm which hemorrhages are CAA related. Patients will be compared with several matched control groups (non CAA related ICH, ischemic stroke, hip fracture, and cataract surgery). Data will be analyzed using conditional logistic regression adjusted for relevant vascular conditions such as hypertension and diabetes.
This study addresses a critical gap in understanding the potential transfusion related transmission of CAA. This will be the first study to directly examine whether CAA can be transmitted through blood transfusion. Results will have significant implications for transfusion safety by clarifying whether amyloid buildup in the brain is linked to blood transfusion. This research will advance our understanding of CAA pathophysiology and inform the development of future surveillance strategies for high risk donors.
Programme
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
559836
Name
Harmon Megan
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
DT2 (Health services and population health research) CGRS Doctoral
Projecttitle
Blood Transfusion and Risk of CAA-Related Intracerebral Hemorrhage: A Nested Case-Control Study
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Beta-Amyloid; Blood Transfusion; Epidemiology; Hemorrhagic Stroke
Abstract
Cerebral amyloid angiopathy (CAA) is a condition in which beta amyloid accumulates in the brain's small blood vessels, making them fragile, contributing to roughly 20 to 50 percent of spontaneous intracerebral hemorrhages (ICH). Evidence suggests these beta amyloid fibrils may be transmissible via infected tissues, resembling prion diseases. Exploratory work found patients receiving blood from donors who later had multiple ICH events faced higher ICH risk, although the link to CAA was not explored. This study investigates whether receiving a blood transfusion is associated with increased odds of CAA related ICH, supporting possible prion like transmissibility of CAA through blood.
In this retrospective, nested case control study, we will use administrative data from 2001 to 2025 to identify patients with ICH. Brain scans will be reviewed to confirm which hemorrhages are CAA related. Patients will be compared with several matched control groups (non CAA related ICH, ischemic stroke, hip fracture, and cataract surgery). Data will be analyzed using conditional logistic regression adjusted for relevant vascular conditions such as hypertension and diabetes.
This study addresses a critical gap in understanding the potential transfusion related transmission of CAA. This will be the first study to directly examine whether CAA can be transmitted through blood transfusion. Results will have significant implications for transfusion safety by clarifying whether amyloid buildup in the brain is linked to blood transfusion. This research will advance our understanding of CAA pathophysiology and inform the development of future surveillance strategies for high risk donors.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Harmon, Megan
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~